26th International Congress of Chemotherapy and Infection
18 – 21 June 2009
Sheraton Centre Toronto Hotel, Toronto, Canada
Every two years, the ISC organises the International Congress of Chemotherapy (ICC) in conjunction with its member societies. The 26th ICC will be co-hosted by the ISC, the Association of Medical Microbiology and Infectious Diseases (AMMI) Canada and the Canadian Society for Clinical Microbiology and Infectious Diseases (CACMID). The theme of the congress is “The Changing Climate of Infectious Diseases” The 26th ICC will be a cutting edge international scientific and clinical congress about microbiology, epidemiology, diagnosis and therapy of infectious diseases as well as antimicrobial chemotherapy. Original presentations on our rapidly changing understanding of infectious disease and chemotherapy will be complemented by overviews from world authorities.
An opening night symposium (June 18th, 17.30 to 19.00) entitled The Emergence of H1N1 Influenza A Virus is co-sponsored by the Public Health Agency of Canada. It will provide updates from Canada, the U.S. and Mexico.
Immediately following the H1N1 Symposium, Dr. Kirsty Duncan, a leading expert in the area of environmental change and the impact on human health, will deliver a special lecture entitled Climate Change – Health Impacts, Responsibilities and Action: Health in a Warmer World.
You can now only register on site.
The Scientific Program is now updated and can be found atwww.icc-09.com To view the FINAL ABSTRACTS please click here.
Raphael Saginur 26th ICC President
Mark Joffe Programme Committee Chair
Kurt G. Naber ISC President
Gerald A. Evans AMMI Canada President
Karam Ramotar CACMID President
International Journal of Antimicrobial Agents
One of ISC’s principle activities is production of the International Journal of Antimicrobial Agents in collaboration with the publisher Elsevier.
The journal is thriving due, in no small part, to the diligence of our Editor-in-Chief: Professor Alasdair Geddes, Birmingham, UK. Professor Geddes is also one of the ISC Trustees.
The journal provides comprehensive and up-to-date peer reviewed reference information on the physical, pharmacological, in vitro and clinical properties of individual antimicrobial agents. In addition, it signals new trends and developments in the field through highly authoritative review articles on antimicrobial agents, immunomodulators and immunotherapy. Special attention is given to articles providing insight into the problems of antimicrobial resistance, local as well as world-wide, both in the hospital and in the community. Papers on the underlying mechanisms and on immunomodulating agents are also welcome. Both solicited reviews by top experts in the mentioned fields and high-quality original research papers are published.
Note * ISC member societies can take advantage of reduced subscription rates.
For further information go to the International Journal of Antimicrobial Chemotherapy click here.
2009
